In the lungs of COPD patients, reductions in HDAC activity and HDAC2 expression are associated with increases in the IL-8 mRNA levels and histone-H4 acetylation at the promoter13. The gene discussed is HDAC9; the disease is chronic obstructive pulmonary disease.